key: cord-0116889-781en2ho authors: Olesen, Scott W.; Imakaev, Maxim; Duvallet, Claire title: Defining the lead time of wastewater-based epidemiology for COVID-19 date: 2021-04-01 journal: nan DOI: nan sha: 19efb614df3f28fd5015ab8272b9acf7df12911b doc_id: 116889 cord_uid: 781en2ho Individuals infected with SARS-CoV-2, the virus that causes COVID-19, may shed the virus in stool before developing symptoms, suggesting that measurements of SARS-CoV-2 concentrations in wastewater could be a"leading indicator"of COVID-19 prevalence. Multiple studies have corroborated the leading indicator concept by showing that the correlation between wastewater measurements and COVID-19 case counts is maximized when case counts are lagged. However, the meaning of"leading indicator"will depend on the specific application of wastewater-based epidemiology, and the correlation analysis is not relevant for all applications. In fact, the quantification of a leading indicator will depend on epidemiological, biological, and health systems factors. Thus, there is no single"lead time"for wastewater-based COVID-19 monitoring. To illustrate this complexity, we enumerate three different applications of wastewater-based epidemiology for COVID-19: a qualitative"early warning"system; an independent, quantitative estimate of disease prevalence; and a quantitative alert of bursts of disease incidence. The leading indicator concept has different definitions and utility in each application. This application is relevant in the context of individual facilities, such as a college dormitory, correctional institution, nursing home, or cruise ship (Ahmed et al. 2020b; Betancourt et al. 2020; Daughton 2020; Harris-Lovett et al. 2021; Peiser 2020; Reeves et al. 2021; Targeted Wastewater Surveillance at Facilities, Institutions, and Workplaces 2020) , as well as in the context of larger wastewater catchments, such as a city with little ongoing transmission of SARS-CoV-2 (Ahmed et al. 2020a ; COVID-19 weekly surveillance reports; Fongaro et al. 2021; Jørgensen et al. 2020; Medema et al. 2020; Randazzo et al. 2020) . If the surveilled population has zero (or very few) known cases but does have detectable SARS-CoV-2 in wastewater, then there are likely one or more individuals in the population with presymptomatic or asymptomatic infections. WBE's lead time in this application is the delay between detection of the virus in wastewater versus the detection of cases by other means, such as if the infected person is identified with a screening test, or if an infected person becomes symptomatic, seeks a diagnostic test, and receives a positive result. Ideally, this lead time allows for the implementation of mitigation measures, like quarantine or mass diagnostic testing, that can prevent an outbreak. In this application, WBE's lead time depends on biological and health systems factors. In terms of biology, WBE's lead time depends on the proportion of infected people who shed detectable levels of virus in their stool as well as the time delay between the onset of viral shedding in feces versus the onset of symptoms (Miura et al. 2021 ). The lead time also depends on health systems factors like the availability of testing, individuals' healthcare seeking behavior, and the turnaround time for returning diagnostic test results and wastewater monitoring measurements (McClary-Gutierrez et al. 2021) . For example, if there are sufficient resources to allow screening everyone in the monitored population for SARS-CoV-2 every day, then wastewater's lead time and added value will be minimal (Peccia et al. 2020) . Conversely, if there is no active case finding in the relevant population, then wastewater, insofar as it can detect the presence of infected individuals before they present with symptoms, could be a "leading indicator" with a lead time at least as long as the delay between onset of fecal shedding and the onset of symptoms, that is, 1 to 6 days (Zhu et al. 2021) . If the turnaround time for diagnostic testing is longer than the turnaround time for wastewater testing, wastewater's lead time will be that much greater. In theory, the biological factors affecting WBE's lead time could include viral lineage. For example, infection with different variants could lead to different presymptomatic shedding patterns. To our knowledge, however, there are no studies that have investigated differences in shedding dynamics by virus variant. The second application of WBE for COVID-19 is as a quantitative, population-level estimate of disease prevalence. Rather than estimating SARS-CoV-2 prevalence using just those individuals who tested positive and were formally counted as a case, wastewater detects virus in a sample formed from the pooled excretions of many individuals Kitajima et al. 2020) , regardless of whether they are symptomatic, have access to healthcare, or whose healthcare system has abundant resources for testing (Medema et al. 2020) . Thus, this application is appealing because it provides estimates that are potentially less biased and less resource-intensive compared to traditional disease monitoring using diagnostic testing (National WBE and diagnostic testing can also provide synergistic insights. If trends in both case rates and wastewater change directions, public health officials can be more certain that disease prevalence has truly passed an inflection point. If wastewater measurements rise while case counts remain stable, then diagnostic testing may be undercounting cases (Fernandez-Cassi et al. 2021; Wu et al. 2020a) . Conversely, if rates of positive diagnostic tests rise but wastewater measurements remain stable, then the apparent increase in cases may be due to increased testing (i.e., less undercounting) rather than to increased prevalence (Gerrity et al. 2021; McClary-Gutierrez et al. 2021 ). In principle, this second application of WBE could be a "leading indicator". Various reports have suggested that correlations between wastewater concentrations of SARS-CoV-2 and reported COVID-19 cases are maximized when cases are lagged by 2 to 8 days (i.e., when wastewater leads cases by 2 to 8 days; Table 1 ). This interpretation, however, is subject to three important caveats. First, to say that wastewater is a "leading indicator" with a lead time of D days does not mean that today's wastewater measurement says exactly how many new cases will be reported D days from now. Of course, neither wastewater measurements nor reported case counts are perfectly accurate: the time series of new case counts, offset by D days, would never perfectly line up with the timeseries of WBE measurements because of measurement error (Gerrity et al. 2021 ). However, even if wastewater measurements and reported case counts were perfectly accurate, we would not expect the two time series to line up, since individuals who are shedding virus in stool today are at different places in their disease trajectories (Hoffman & Alsing 2021; Miura et al. 2021 ). Some will become symptomatic sooner, some later, and some not at all. Some may already have become counted as reported cases. In other words, there are multiple factors that delay cases counts relative to the onset of fecal shedding: disease time courses, healthcare seeking behavior, access to testing, and testing turnaround time. These delays mean that the timeseries of new case counts is offset relative to WBE measurements. However, there is also variability in those factors, which leads to a smoothing of case counts relative to shedding rates (Fernandez-Cassi et al. 2021; Wu et al. 2020b ). This combination of shifting and smoothing means that the temporal relationship between wastewater measurements and case counts is complex (Weidhaas et al. 2021) . Second, even insofar as a single lead time is meaningful for two signals that do not perfectly align, that lead time will vary across populations and through time in a single population, and it will vary depending on the statistical methodology used (Table 1, Figure 1 ). From a biological point of view, we would expect the lead time to change depending on who is being infected, their disease severity, and the precise SARS-CoV-2 variant that infected them (Cevik et al. 2020; Kissler et al. 2021) . From a health systems point of view, the delay between shedding virus and becoming a reported case depends on the availability and accessibility of diagnostic tests. More testing and faster turnaround time means shorter lead time. Thus, we should not expect that studies will all report the same lead time for this application of WBE for COVID-19. Third, even accounting for all the variability mentioned above, there may be many lead times that describe the relationship between WBE measurements and reported case counts nearly equally well (Figure 1 ; D'Aoust et al. 2021; Graham et al. 2021) . Thus, it is not the case that wastewater signals are well correlated only with case rates exactly D days in the future; instead, wastewater correlates positively with case rates over many days in the future. Asserting that the "best" lead time is the one that maximizes this correlation thus ignores other factors important to public health practitioners. It might be preferable, for example, to maximize a practitioner's early warning by having a slightly poorer prediction of case rates at a greater lead time than the numerically optimal prediction at a shorter lead time. Given the complexity around wastewater's lead time in this application, we hypothesize that WBE has more value as an independent measurement of population-level disease prevalence rather than as a precise leading indicator of prevalence (Reeves et al. 2021) . As an analogy, we note that influenza monitoring systems include counts of laboratory-confirmed influenza-related hospitalizations as well as counts of outpatient visits for influenza-like illness. In principle, outpatient visits could be a leading indicator of hospitalizations because individuals with severe disease would visit a physician before becoming hospitalized. However, the main value of outpatient visits for influenza monitoring is not as a leading indicator but rather as a complementary window onto disease prevalence. We speculate that a few days' extra notice is not as important as having an independent confirmation that flu season is generally accelerating, or has peaked and is on the decline. Analogously, for this application, WBE's primary value is in providing an independent confirmation that COVID-19 prevalence is generally high or low, or generally rising or falling, rather than having a lead time of 2 to 8 days (Gonzalez et al. 2020) . In resource-limited settings with very limited testing, where wastewater-based testing could in theory be the primary mechanism for disease prevalence monitoring (Hart & Halden 2020) , this logic would hold even more strongly: WBE's primary value would be in measuring COVID-19 prevalence, rather than in being a leading indicator relative to the limited number of diagnostic tests. The third application is to detect a rapid change, or "burst", in disease incidence using wastewater measurements on a background of ongoing transmission. For example, given daily wastewater sampling through a holiday or special event, such as Thanksgiving or the Superbowl in the US, how many excess infections occurred specifically because of that event? This information could help public health officials estimate the timing and magnitude of the resulting surge in cases and hospitalizations following those events. As another example, given regular wastewater sampling at a congregate living facility where convalescent shedders from a previous outbreak have been identified and isolated, can a second, unrelated outbreak be rapidly detected and distinguished from the first outbreak? In this application, WBE would be a "leading indicator" insofar as it would provide an alert about the burst in disease activity before other monitoring systems, like case counts, would. However, to our knowledge, this application has seen only anecdotal and not quantitatively rigorous use (Fox 2020) , likely because it is substantially more complex than the first two. Unlike Application 1, this application must deliver a quantitative estimate of disease incidence (i.e., the change in the number of infected individuals), not just a simple presence/absence determination. Unlike Application 2, which involves identifying trends in disease activity over weeks, this application requires quantifying changes in trends that occur rapidly, perhaps on the timescale of days rather than weeks. This short timescale exacerbates the analytical challenges faced by the other applications, including the variability in wastewater measurements and case counts. Validating this application will be especially challenging, as it would require establishing a gold standard of true disease incidence to compare its predictions against. Case counts, although an attractive indicator of disease activity, cannot themselves be the gold standard because of their weekly patterns (e.g., fewer cases counted on weekends) and their unusual behavior during holidays and special events (e.g., the anomalous case count patterns during the major US holidays in November and December 2020). Rolling 7-day averages of case counts are also an inappropriate gold standard. Although weekly rolling averages are not subject to within-week variations in case reporting, they obscure exactly the short-term bursts in incidence this application aims to detect (Bloom et al. 2007 ). Thus, a robust burst-detection algorithm likely needs to include a sophisticated statistical inference of underlying disease incidence, which remains an area of ongoing research (Li et al. 2021) . • There are at least three distinct applications of WBE for COVID-19: (1) qualitatively detecting new infections on a background of little or no disease activity, (2) independently estimating COVID-19 prevalence and trends, and (3) detecting sudden increases in disease incidence. • WBE can be a "leading indicator", but there is no one single "lead time" because the lead time depends on the application of WBE, and it depends on biological, epidemiological, and health systems factors. • For Application 1, wastewater is a leading indicator insofar as it can identify new infections before those individuals would be identified by some other method. If there are sufficient resources to allow screening everyone in the monitored population for SARS-CoV-2 every day, then wastewater likely leads reported case counts by very little time, if any. If there is no active case finding, then WBE is a leading indicator of at least 2 to 8 days, that is, the time between when an individual begins shedding detectable virus in their stool and when they seek diagnostic testing. • The primary value of Application 2 may be that WBE measurements are unaffected by access to testing, healthcare-seeking behaviors, or other socio-behavioral factors. Thus, for this application, WBE may be more valuable because it is an independent indicator of disease prevalence, rather than because it can be a leading indicator. • Application 3, detecting sudden increases in disease incidence on a background of high disease prevalence, will pose substantial technical challenges. (a) Spearman: Spearman correlation between 7-day average case counts (i.e., mean number of new case counts over the day of wastewater sampling and the previous 6 days) and wastewater virus concentrations. This is the baseline analysis. (a) Pearson: Pearson correlation between 7-day average case counts and wastewater virus concentrations. (a) Pearson (log): Pearson correlation between 7-day average case counts and base-10 logarithms of wastewater virus concentrations. (b) 7-day average (lagging): Baseline analysis; same as (a) Spearman. (b) 7-day average (center): Spearman correlation between centered 7-day average case counts (i.e., mean number of new case counts over the day of wastewater sampling, the preceding 3 days, and the following 3 days) and wastewater virus concentrations. (b) Raw case counts: Spearman correlation between daily number of new case counts (without smoothing) and wastewater virus concentrations. (c) Baseline analysis like in (a) Spearman, but using data only from each calendar quarter (e.g., First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers Wastewater-based Epidemiology for Averting COVID-19 Outbreaks on The University of Arizona Campus. Cold Spring Harbor Laboratory Finding Leading Indicators for Disease Outbreaks: Filtering, Cross-correlation, and Caveats SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The Lancet Microbe COVID-19 weekly surveillance reports Catching a resurgence: Increase in SARS-CoV-2 viral RNA Wastewater surveillance for population-wide Covid-19: The present and future Evaluation of sampling frequency and normalization of SARS-CoV-2 wastewater concentrations for capturing COVID-19 burdens in the community. Cold Spring Harbor Laboratory Wastewater monitoring outperforms case numbers as a tool to track COVID-19 incidence dynamics when test positivity rates are high The presence of SARS-CoV-2 RNA in human sewage Small uptick in virus detected in wastewater at MWRA plant Available from Early-pandemic wastewater surveillance of SARS-CoV-2 in Southern Nevada: Methodology, occurrence, and incidence/prevalence considerations COVID-19 surveillance in Southeastern Virginia using wastewater-based epidemiology SARS-CoV-2 RNA Cases in a Large Urban Sewershed Wastewater surveillance for SARS-CoV-2 on college campuses: Initial efforts, lessons learned and research needs. medRxiv Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges Innovation in wastewater near-source tracking for rapid identification of COVID-19 in schools. The Lancet Microbe Faecal shedding models for SARS-CoV-2 RNA amongst hospitalised patients and implications for wastewater-based epidemiology Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19 Eurofins Covid-19 Sentinel™ Wastewater Test Provide Early Warning of a potential COVID-19 outbreak. Cold Spring Harbor Laboratory Developing a Flexible National Wastewater Surveillance System for COVID-19 and Beyond. Environ Health Perspect Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. Cold Spring Harbor Laboratory SARS-CoV-2 in wastewater: State of the knowledge and research needs Unravelling the early warning capability of wastewater surveillance for COVID-19: A temporal study on SARS-CoV-2 RNA detection and need for the escalation Coupling freedom from disease principles and early warning from wastewater surveillance to improve health security. medRxiv Tracking COVID-19 with wastewater Data-driven estimation of COVID-19 community prevalence through wastewater-based epidemiology. Science of The Total Environment Sars-CoV-2 wastewater surveillance for public health action: Connecting perspectives from wastewater researchers and public health officials during a global pandemic Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands. Environmental Science & Technology Letters Duration of SARS-CoV-2 viral shedding in faeces as a parameter for wastewater-based epidemiology: Re-analysis of patient data using a shedding dynamics model US Centers for Disease Control and Prevention Temporal Detection and Phylogenetic Assessment of SARS-CoV-2 in Municipal Wastewater Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics The University of Arizona says it caught a dorm's covid-19 outbreak before it started. Its secret weapon: Poop Making waves: Wastewater-based epidemiology for COVID-19 -approaches and challenges for surveillance and prediction RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area High-resolution within-sewer SARS-CoV-2 surveillance facilitates informed intervention Targeted Wastewater Surveillance at Facilities, Institutions, and Workplaces US Centers for Disease Control and Prevention US Coronavirus Cases & Deaths by State USA Facts Wastewater COVID-19 Tracking Massachusetts Water Resources Authority Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewersheds SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases SARS-CoV-2 titers in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases. medRxiv Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks We thank Eric Alm, Mary Bushman, Nour Sharara, and Amy Xiao for helpful discussions. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. SO, MI, and CD are employees of Biobot Analytics, Inc.